Skip to main content

Table 2 Percent distribution of all participants according to knowledge (N = 120)

From: Knowledge of the Egyptian emergency physicians about the use of rt-PA in acute ischemic stroke

 

True

False

Do not know

N

%

N

%

N

%

Is rt-PA, used in the treatment of AIS, a legislated drug?

76

63.3

4

3.3

40

33.3

Can rt-PA be used in the treatment of AIS?

116

96.7

4

3.3

0

0.0

Is rt-PA the best possible treatment option of AIS?

108

90

12

10

0

0.0

Is antiplatelet agent alone or in combination with a neuroprotective agent is the best possible treatment option of AIS?

80

66.7

28

23.3

12

10

Is heparin the best possible treatment option of AIS?

96

80

12

10

12

10

Are neuroprotective agents such as citicholine or edavarone the best possible treatment option of AIS?

76

63.3

8

6.7

36

30

Is the Window period for rt-PA 4.5 h?

64

53.3

52

43.3

4

3.3

Is Intravenous thrombolytic therapy for AIS the best treatment route of AIS?

84

70

4

3.3

32

26.7

Do we have to control the blood pressure in AIS before using rt-PA?

72

60

16

13.3

32

26.7

Do we have to control the blood glucose level in AIS before using rt-PA?

8

6.7

80

66.7

32

26.7

Are intravenous fluids used in AIS?

64

53.3

36

30

20

16.7

Total score (11)

Mean 7 ± 1.8

  1. N number, % percentage, rt-PA recombinant tissue plasminogen activator, AIS acute ischemic stroke